← Eichor
Condition: Primary Hyperoxaluria Type 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Hyperoxaluria Type 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Pap
Phase 2 · 1 location(s) · Novartis Pharmaceuticals · NCT07681271Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Phase 2 · 18 location(s) · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · NCT04580420Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
EARLY_Phase 1 · 1 location(s) · RenJi Hospital · NCT06511349Rare Kidney Stone Consortium Biobank
Phase N/A · 1 location(s) · Mayo Clinic · NCT02026388Prospective Research Rare Kidney Stones (ProRKS)
Phase N/A · 11 location(s) · Mayo Clinic · NCT02780297Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Phase 1/Phase 2 · 7 location(s) · Arbor Biotechnologies · NCT06839235Monogenic Kidney Stone - Genetic Testing
Phase N/A · 1 location(s) · Mayo Clinic · NCT03305835National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Rare Kidney Stone Consortium Patient Registry
Phase N/A · 4 location(s) · Mayo Clinic · NCT00588562Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.
Phase N/A · 7 location(s) · Hospices Civils de Lyon · NCT06225882
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.